Home › All Companies › BNBX › Quarterly Report

BNB PLUS CORP. (BNBX) — Quarterly Report

AI-Powered SEC Filing Analysis

← All BNBX filings
Latest Quarterly Report Filed: 2026-02-12

Key Insights

  • The company reported a 25% year-over-year increase in revenue for the Therapeutic DNA Production segment during Q1 2025, suggesting strong demand for its products.
  • The company's consulting arrangements with Ground Tunnel Capital LLC and Cypress Management LLC indicate strategic partnerships that could unlock new business opportunities.
  • The company raised $400,000 through an at-the-market offering in Q4 2025, which could provide additional capital to fund growth initiatives.
Sentiment: Positive Significance: 6/10
View Original Filing →

Want the newest filings?

This analysis covers the filing from 2026-02-12. New 10-K, 10-Q and 8-K filings are analyzed the moment they are released — exclusively in the app.

Download on the App Store Open in app →

Other reports for BNB PLUS CORP.

Current Report Insider Trading

Important Information

AI-generated analysis is for informational purposes only. Always read original SEC filings and consult with qualified professionals before making investment decisions.